Zami Aberman Insider Trading $AISF PLURISTEM THERAPEUTICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Zami Aberman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Zami Aberman. Zami Aberman is CEO & Chairman in PLURISTEM THERAPEUTICS INC ($AISF) and CEO & Co. Chairman in PLURISTEM THERAPEUTICS INC ($AISF).
Zami Aberman in PLURISTEM THERAPEUTICS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Zami Aberman: CEO & Chairman, CEO & Co. Chairman
Holdings: 1,768,298 shares
Latest Transaction: Nov 12 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Zami Aberman in PLURISTEM THERAPEUTICS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 12 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.65 | 6,500 | 17,225 | 1,768,298 | 1.8 M to 1.8 M (+0.37 %) |
| Nov 12 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.62 | 6,500 | 17,030 | 1,761,798 | 1.8 M to 1.8 M (+0.37 %) |
| Sep 23 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.92 | 5,000 | 14,600 | 1,755,298 | 1.8 M to 1.8 M (+0.29 %) |
| Sep 22 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.97 | 2,500 | 7,425 | 1,750,298 | 1.7 M to 1.8 M (+0.14 %) |
| Sep 22 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.94 | 2,500 | 7,350 | 1,747,798 | 1.7 M to 1.7 M (+0.14 %) |
| Sep 17 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.84 | 15,000 | 42,600 | 1,745,298 | 1.7 M to 1.7 M (+0.87 %) |
| Sep 16 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.80 | 15,000 | 42,000 | 1,730,298 | 1.7 M to 1.7 M (+0.87 %) |
| Jan 14 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Sell | S | 4.30 | 67,850 | 291,484 | 1,715,298 | 1.8 M to 1.7 M (-3.81 %) |
| Jan 14 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Sell | S | 4.25 | 2,000 | 8,500 | 1,783,148 | 1.8 M to 1.8 M (-0.11 %) |
| Jan 09 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Sell | S | 4.25 | 150 | 638 | 1,785,148 | 1.8 M to 1.8 M (-0.01 %) |
| Jan 09 2014 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Sell | S | 4.25 | 30,000 | 127,500 | 1,785,298 | 1.8 M to 1.8 M (-1.65 %) |
| Dec 26 2013 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 150,000 | 0 | 1,815,298 | 1.7 M to 1.8 M (+9.01 %) |
| Jun 27 2013 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 350,000 | 0 | 1,665,298 | 1.3 M to 1.7 M (+26.61 %) |
| Aug 21 2012 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Sell | S | 5.00 | 33,853 | 169,265 | 1,315,298 | 1.3 M to 1.3 M (-2.51 %) |
| Dec 22 2011 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 350,000 | 0 | 1,349,151 | 999.2 K to 1.3 M (+35.03 %) |
| May 19 2011 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 150,000 | 0 | 999,151 | 849.2 K to 999.2 K (+17.66 %) |
| Jan 20 2011 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Sell | S | 3.20 | 25,000 | 80,000 | 849,151 | 874.2 K to 849.2 K (-2.86 %) |
| Jan 13 2011 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Sell | S | 2.60 | 25,000 | 65,000 | 874,151 | 899.2 K to 874.2 K (-2.78 %) |
| Nov 01 2010 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 160,000 | 0 | 899,151 | 739.2 K to 899.2 K (+21.65 %) |
| Aug 12 2010 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 200,000 | 0 | 739,151 | 539.2 K to 739.2 K (+37.10 %) |
| May 12 2010 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 85,563 | 0 | 542,799 | 457.2 K to 542.8 K (+18.71 %) |
| Dec 24 2009 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 140,000 | 0 | 457,236 | 317.2 K to 457.2 K (+44.13 %) |
| May 13 2009 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 38,700 | 0 | 317,236 | 278.5 K to 317.2 K (+13.89 %) |
| Feb 12 2009 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Co. Chairman | Grant | A | 0.00 | 140,000 | 0 | 278,536 | 138.5 K to 278.5 K (+101.06 %) |
| Jan 26 2009 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Co. Chairman | Option Exercise | A | 0.62 | 110,000 | 68,200 | 110,000 |
Page: 1